99mTc-ADAPT6

· Tomsk National Research Medical Center of the Russian Academy of Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 99mTc-ADAPT6, covering 2023-04-20 to 2023-04-20. Get the full timeline:

Most recent: Clinical Trial Update: 99mTc-ADAPT6 SPECT-based Non-invasive Quantification of HER2-expression in Breast Cancer With Metastatic Lymph Nodes [Phase 2]

See pricing